Biogen - PDFSEARCH.IO - Document Search Engine

Biogen
Results: 197

#	Item
111	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:23 Élan Progressive multifocal leukoencephalopathy Health Medicine IDEC Biology Immunosuppressants Biogen Idec Natalizumab
112	[removed]Professional Educators of North Carolina: PENC eNews - June 28, 2013 June 28, 2013 Add to Reading List Source URL: penc.memberclicks.net Language: English - Date: 2014-06-12 15:21:31 Biogen Idec Raleigh North Carolina Geography of the United States Education reform IDEC Common Core State Standards Initiative
113	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:24 Élan Progressive multifocal leukoencephalopathy Health Medicine IDEC Pakistan Muslim League Biology Immunosuppressants Natalizumab Biogen Idec
114	Biogen Idec (Labeler Code[removed]Re-Calculation of 340B Ceiling Prices for Q3 2005 through Q3 2007 Add to Reading List Source URL: www.hrsa.gov Language: English - Date: 2012-10-04 17:58:42 Medicaid Biology Economy of the United States Biogen Idec IDEC Interferon beta-1a
115	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:23 Élan Progressive multifocal leukoencephalopathy IDEC Health Medicine Biology Immunosuppressants Natalizumab Biogen Idec
116	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-02-17 10:44:24 Élan Progressive multifocal leukoencephalopathy Health Medicine IDEC Biology Immunosuppressants Natalizumab Biogen Idec
117	Microsoft Word[removed]NOV Tysabri webcast.doc Add to Reading List Source URL: www.fda.gov Language: English Immunology Natalizumab Multiple sclerosis Progressive multifocal leukoencephalopathy Biogen Idec Food and Drug Administration JC virus Immunosuppressants Health Medicine
118	TYSABRI® RISK MINIMIZATION ACTION PLAN: SUMMARY OF TOUCHSM Add to Reading List Source URL: www.fda.gov Language: English Natalizumab Biogen Idec Pharmacology Medical prescription Progressive multifocal leukoencephalopathy Medicine Health Immunosuppressants
119	DRAFT Appeal Letter – Tecfidera TODAY’s DATE Health Plan Addressee Line 1 Health Plan Addressee Line 2 Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-01-15 23:48:04 Health Glatiramer acetate Biogen Idec Dimethyl fumarate Placebo Therapies under investigation for multiple sclerosis Corinne Goldsmith Dickinson Center for Multiple Sclerosis Medicine Multiple sclerosis Immunology
120	Multiplehttp://msj.sagepub.com/ Sclerosis Journal Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS Robert J Fox, Alan Thompson, David Baker, Peer Baneke, Dou Add to Reading List Source URL: msj.sagepub.com Language: English Medicine Natalizumab Biogen Idec Multiple Sclerosis Journal National Multiple Sclerosis Society Corinne Goldsmith Dickinson Center for Multiple Sclerosis Dirucotide Multiple sclerosis Immune system Immunology

UPDATE